ADAPY
Adaptimmune Therapeutics Plc - ADR

10,099
Mkt Cap
$16.17M
Volume
3.93M
52W High
$0.74
52W Low
$0.0202
PE Ratio
-0.09
ADAPY Fundamentals
Price
$0.059
Prev Close
$0.061
Open
$0.0627
50D MA
$0.0989
Beta
1.01
Avg. Volume
112.85M
EPS (Annual)
-$0.2808
P/B
-0.23
Rev/Employee
$351,989.95
Loading...
Loading...
Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
506

Frequently Asked Questions

What is Market Cap of Adaptimmune Therapeutics Plc - ADR?
What is the 52-week high for Adaptimmune Therapeutics Plc - ADR?
What is the 52-week low for Adaptimmune Therapeutics Plc - ADR?
What is Adaptimmune Therapeutics Plc - ADR stock price today?
What was Adaptimmune Therapeutics Plc - ADR stock price yesterday?
What is the PE ratio of Adaptimmune Therapeutics Plc - ADR?
What is the Price-to-Book ratio of Adaptimmune Therapeutics Plc - ADR?
What is the 50-day moving average of Adaptimmune Therapeutics Plc - ADR?
How many employess does Adaptimmune Therapeutics Plc - ADR has?

Latest ADAPY News

View
No ADAPY news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.